Doyen Elements is planning to publicly list its shares on the OTC Market, but early investors won’t have to wait. The cultivator said it was accepting investments now prior to its IPO at $7.00 a share. Doyen Elements has big plans and is currently building one of the largest grow facilities in North America. This 234,000 sq. ft. behemoth of a building will be capable of producing upwards of 70,000 pounds of cannabis per year. According to the company, this building will be the first of many self-contained grow facilities the company will lease out to legal cannabis companies.
The grow facility is located in Pueblo Colorado in an abandoned Pepsi factory. The project has strong community support since it has taken a derelict building and breathed new life into it. In addition to its own facility, Doyen Elements is planning on building a portfolio of real estate assets in order to lease them out to licensed cultivators and dispensary owners. The goal is to have over a million sq. ft. of grow space across the country.
Doyen is also trying to assemble a collection of cannabis companies. According to the company statement, “Equity Purchase Agreements are in place to acquire 16 long-standing, high-performing companies that span across all areas of the Cannabis Industry.” The companies are involved in multiple areas of the industry, from management, green technology, to research, etc, each company operates 100% independently from one another. The strategy behind the company portfolio is to allow “Doyen Elements the opportunity to profit from 16 different revenue streams while giving investors access to a diversified portfolio of companies in the industry. Also by cross-selling its services the company will obtain a higher ROI on client acquisition costs.”
Once the offering closes Doyen Elements plans to list on the OTC stock exchange.
23 comments
Donald Kinsler
January 4, 2018 at 11:21 am
How do I start purchasing pre IPO shares?
HK
January 10, 2018 at 1:48 pm
Their website is currently down, but once it is back up, here is where you purchase the pre-IPO shares: https://doyenelements.com/invest/
William Miears
January 31, 2018 at 7:16 pm
I have been unable to get any response to my inquiries about status of my purchase of 100 shares of pre ipo stock a couple months ago. Should I post my worries on my wife’s Facebook page or will some one in your company please let me know what is going on? I got a response several weeks ago and then your email address was no longer valid. Please
advise.
Kind regards,
William Miears
Debra Borchardt
February 1, 2018 at 8:42 am
Hi William, I can’t speak for the company and suggest you should contact their investor relations. We only reported that they were offering shares and had nothing to do with the actual offering. My understanding and it hasn’t been confirmed is that the company is hoping to go public in Canada and those pre-IPO shares will convert over to the new deal. You should contact Doyen.
Andy samp
February 21, 2018 at 10:23 pm
Was this ever resolved?
VIP Host DREA'S
December 23, 2019 at 9:34 am
Mr Samp,
Hope all is well. Everything is going great with your money. I am investing you money well. I am currently out of the country but can tell you this is the best investment you could of done.
Be sure when this pays out to take care of your friends.
You know who they are….
VIP HOST DREA”S
John Kennedy
June 15, 2018 at 12:19 pm
Is Doyen Elements still in business?
Debra Borchardt
June 17, 2018 at 8:41 am
Yes and I believe they are actually going to be rebranding and changing the company name.
wendy
June 20, 2018 at 8:41 pm
this is doyen elements ceo a total bust out
U.S. Securities & Exchange Commission
SEC Seal
Home | Previous Page
U.S. Securities and Exchange Commission
U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 23969 / October 19, 2017
Securities and Exchange Commission v. Accelera Innovations, Inc., et al., No. 17-cv-7052 (N.D. Ill. filed Sept. 29, 2017)
Securities and Exchange Commission v. John F. Wallin, No. 17-cv-7057 (N.D. Ill. filed Sept. 29, 2017)
SEC Files Fraud Charges Against Microcap Company and its Founder
The Securities and Exchange Commission has charged a microcap company and its founder with fraud for painting a misleading picture of the company’s finances that deceived the investing public about its true financial condition as well as its technology.
The SEC’s complaint, filed on September 29, 2016, alleges that Accelera Innovations Inc.’s public filings included the revenues of a separate company that it did not own or control and, as a result, Accelera improperly inflated its annual revenue by up to 90 percent. In addition, the complaint alleges that Accelera portrayed itself as a provider of software when, in reality, it was not providing software to anyone. Geoffrey Thompson, Accelera’s founder, allegedly signed Accelera’s annual reports. The complaint also alleges that Thompson, acting through Accelera and Synergistic Holdings LLC, sold approximately $1.7 million worth of Accelera stock to investors, and that the sale was not registered or subject to any exemption from registration.
The SEC’s complaint, filed in the U.S. District Court for the Northern District of Illinois, charge:
Accelera, Thompson, and Synergistic with violating Sections 5(a) and (c) of the Securities Act of 1933;
Accelera and Thompson with violating Section 17(a) of the Securities Act and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder;
Accelera with violating Section 13(a) of the Exchange Act and Rules 13a-1 and 13a-13 thereunder; and
Thompson with aiding and abetting Accelera’s violations of Section 13(a) of the Exchange Act and Rules 13a-1 and 13a-13 thereunder.
The complaint seeks permanent injunctions, disgorgement of ill-gotten gains, civil penalties, an officer-and-director bar against Thompson, and penny stock bars against Thompson and Synergistic.
The SEC separately charged John Wallin, Accelera’s Chief Executive Officer and Chief Financial Officer, with signing certifications as to the accuracy of Accelera’s Forms 10-K and 10-Q that falsely attested that he had reviewed Accelera’s financial statements when he had not. The complaint, filed in the U.S. District Court for the Northern District of Illinois, charges Wallin with aiding and abetting Accelera’s violations of Section 13(a) of the Exchange Act and Rules 13a-1 and 13a-13 thereunder and with violating Rule 13a-14 under the Exchange Act. Without admitting or denying the SEC’s allegations, Wallin agreed to the entry of a judgment that permanently enjoins him from violating the charged provisions of the federal securities laws and permanently bars him from acting as an officer or director. The judgment also provides that the amount of any civil penalty will be determined by the court at a future date. The settlement is subject to court approval.
The SEC also separately charged Daniel Caravette, of St. Charles, Ill., with acting as an unregistered broker-dealer. Caravette’s alleged violations involved sales of stock in Accelera and a Canadian company founded by Thompson which claimed to be involved in medical marijuana production, distribution, infusion, research, and testing. The SEC found that Caravette’s transactions violated Section 15(a)(1) of the Exchange Act and Sections 5(a) and 5(c) of the Securities Act. Without admitting or denying the SEC’s findings, Caravette agreed to the entry of an order requiring him to cease-and-desist from violating the charged provisions of the federal securities laws, to pay a total of $307,724.78, consisting of $243,332.13 in disgorgement, $24,392.65 in interest, and a $40,000 civil penalty, and to be barred from the industry, with a right to apply for reentry after three years.
The SEC’s investigation in this matter is continuing
Debra Borchardt
June 21, 2018 at 2:56 pm
Thompson resigned from the company and returned shares November 2017.
Janet ruhl
July 6, 2018 at 2:59 pm
Should I be concern about my investment with this company
Debra Borchardt
July 9, 2018 at 8:24 am
I believe the company is rebranding and changing its name, which is not uncommon.
tom
July 9, 2018 at 5:47 pm
yes many people are pissed apparently what i am hearing is millions have been misappropriated
EJ
October 12, 2018 at 3:12 pm
Debra,
What is going on with Doyen Elements, is this company moving forward or are they done?
Trint
December 21, 2018 at 7:16 am
I invested in Doyens Elements earlier this year and I haven’t heard anything but the website says a announcement is coming soon what is up.
Debra Borchardt
December 21, 2018 at 7:46 am
Good question. They rebranded and then went silent. I’ll try to reach out and find out what is going on.
Lori
January 16, 2019 at 8:00 pm
Did you find out anything on Doyen Elements?
Debra Borchardt
January 17, 2019 at 9:18 am
They are renaming the company as Covalence. The rumor is that partners had a falling out, but I can’t confirm this. I am also hearing that the conflict has been resolved and the remaining partners will be resurfacing soon.
Luis Dominguez
January 23, 2019 at 5:41 pm
We also purchased some shares on 2017 and been chasing these company ever since with no luck at all, if anybody can shed some light on how to reach them please share the info. This smells like a scam so we need to know if we should proceed with a legal sue?
Debra Borchardt
January 24, 2019 at 8:22 am
Here is the latest on the company: https://www.greenmarketreport.com/covalent-rebrand-ceo/
Good luck!
Mike
May 4, 2019 at 1:29 pm
Geoff Thompson is probably the biggest crook on the planet. Anyone that gives him a dime will never see it again!!
john
June 5, 2019 at 11:53 am
Oh boy
SEC Files Subpoena Enforcement Action Against a Network of Cannabis Businesses for Failure to Produce Documents in Investigation (SEC Release)
https://www.sec.gov/litigation/litreleases/2019/lr24489.htm
The SEC filed a subpoena enforcement action in the United States District Court for the Northern District of Illinois against Covalent Collective, Inc. f/k/a Doyen Elements International, Inc. f/k/a Advantameds Solutions, Inc. (“Doyen”) for failure to produce documents in an investigation.The SEC alleges that Doyen, through its founder, Geoffrey Thompson, may have violated the registration provisions of the securities laws by engaging in an unregistered offering of securities, and may also have made misleading representations to investors and potential investors about the operations, acquisitions, and projected stock price of Doyen and related entities. The SEC Release admonishes that:
The SEC is continuing its fact-finding investigation and, to date, has not concluded that anyone has violated the securities laws.
Ed Muren
December 15, 2019 at 2:16 pm
Has Covalent folded up?